Electrocardiogram Clinical Validation Study
Completed · Not applicable
Conditions studied: Atrial Fibrillation
In brief
The purpose of the study is to confirm the Garmin ECG (electrocardiogram) software algorithm can detect and classify atrial fibrillation and normal sinus rhythm on single lead ECG data derived from a Garmin wrist-worn, consumer device. The study will also confirm the software's ability to create a Lead I ECG that is clinically equivalent to a reference device. The Garmin ECG software is not a diagnostic system and is intended for informational purposes only.
Key facts
- Study ID
- NCT04842123
- Run by
- Garmin International
- People needed
- 568
- Starts
- 2021-03-31
- Expected to finish
- 2021-10-04
- Last updated by the study team
- 2022-02-03
Who can join
Age: 22 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Able to read, understand, and provide written informed consent;
- Willing and able to participate in the study procedures as described in the consent form;
- Individuals who are 22 years of age and older;
- Able to communicate effectively with and follow instructions from the study staff;
- Have a wrist circumference that fits within the device band; and
- For subjects enrolled into the AF population, subjects must have a known diagnosis of AF and be in AF at the time of screening.
You may not qualify if…
- Physical disability that precludes safe and adequate testing;
- Mental impairment resulting in limited ability to cooperate;
- Subjects with a pacemaker or implantable cardioverter-defibrillator (ICD);
- Acute myocardial infarction within 90 days of screening or other cardiovascular disease that, in the opinion of the Investigator, increases the risk to the subject or renders data uninterpretable;
- Acute pulmonary embolism, pulmonary infarction, or deep vein thrombosis within 90 days of screening;
- Stroke or transient ischemic attack within 90 days of screening;
- Subjects taking rhythm control drugs;
- Symptomatic (or active) allergic skin reactions such as eczema, rosacea, impetigo, dermatomyositis, or allergic contact dermatitis on both wrists or over electrode attachment sites, including known allergy or sensitivity to silicone bands primarily used in wrist-worn fitness devices;
- Known sensitivity to medical adhesives, isopropyl alcohol, watch bands, or ECG electrodes;
- A history of abnormal life-threatening rhythms as determined by the Investigator;
- Significant tremor that prevents subject from being able to hold still;
- Women who are pregnant at the time of study participation; and
- Subjects enrolled into the SR population must not have any diagnosis of AF.
Where it is running
- Hope Research Institute — Phoenix, Arizona, United States
- MedStar Washington Hospital Center — Washington D.C., District of Columbia, United States
- HealthEast — Saint Paul, Minnesota, United States
- Northwell Health North Shore University Hospital — Manhasset, New York, United States
- Northwell Health Lenox Hill Hospital — New York, New York, United States
- MedStar Health Cardiac Electrophysiology at Fairfax — Fairfax, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.